{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:46:36Z","timestamp":1776494796312,"version":"3.51.2"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019402","name":"Puma Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.neo.2022.100806","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T18:02:51Z","timestamp":1652205771000},"page":"100806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0716-238X","authenticated-orcid":false,"given":"Kate R.","family":"Secombe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imogen A.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6564-7927","authenticated-orcid":false,"given":"Anthony D.","family":"Wignall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy M.","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne M.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2022.100806_bib0001","series-title":"FDA approves neratinib for metastatic HER2-positive breast cancer","year":"2020"},{"issue":"3","key":"10.1016\/j.neo.2022.100806_bib0002","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00280-018-3756-8","article-title":"Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model","volume":"83","author":"Secombe","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.neo.2022.100806_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40261-018-0719-0","article-title":"Safety and efficacy profile of neratinib: a systematic review and meta-analysis of 23 prospective clinical trials","volume":"39","author":"Tao","year":"2019","journal-title":"Clin Drug Investig"},{"issue":"4","key":"10.1016\/j.neo.2022.100806_bib0004","first-page":"3546","article-title":"Risk of gastrointestinal events during neratinib therapy in patients with cancer: a systematic review and meta-analysis of clinical trials","volume":"12","author":"Chen","year":"2019","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.neo.2022.100806_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1470-2045(15)00551-3","article-title":"Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Chan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.neo.2022.100806_bib0006","article-title":"Effect of prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2-positive early-stage breast cancer: Phase II CONTROL trial","volume":"80","author":"Chan","year":"2020","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.neo.2022.100806_bib0007","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.annonc.2020.05.012","article-title":"Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial","volume":"31","author":"Barcenas","year":"2020","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.neo.2022.100806_bib0008","first-page":"1843","article-title":"Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases","volume":"21","author":"Stringer","year":"2013","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.neo.2022.100806_bib0009","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1099\/mic.0.000149","article-title":"Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice","volume":"161","author":"Pedroso","year":"2015","journal-title":"Microbiology"},{"key":"10.1016\/j.neo.2022.100806_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1534735420928493","article-title":"Diarrhea induced by small molecule tyrosine kinase inhibitors compared with chemotherapy: potential role of the microbiome","volume":"19","author":"Secombe","year":"2020","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"10.1016\/j.neo.2022.100806_bib0011","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00280-020-04040-0","article-title":"The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats","volume":"85","author":"Mayo","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.neo.2022.100806_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12282-020-01133-9","article-title":"Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant","volume":"28","author":"Secombe","year":"2021","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100806_bib0013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrc.2017.13","article-title":"Microbiota: a key orchestrator of cancer therapy","volume":"17","author":"Roy","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.neo.2022.100806_bib0014","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","article-title":"Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.neo.2022.100806_bib0015","first-page":"2677","article-title":"Antibiotic use is a negative predictor of the efficacy and toxicity of epidermal growth factor receptor-targeted therapy in advanced non-small cell lung cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.neo.2022.100806_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkw383","article-title":"Short- and long-term effects of oral vancomycin on the human intestinal microbiota","volume":"72","author":"Isaac","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.neo.2022.100806_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2310\/6620.2009.09073","volume":"21","author":"Sasseville","year":"2010","journal-title":"Neomycin. Dermatitis,"},{"issue":"7","key":"10.1016\/j.neo.2022.100806_bib0018","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/TP.0000000000002169","article-title":"Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection","volume":"102","author":"Rey","year":"2018","journal-title":"Transplantation"},{"issue":"13","key":"10.1016\/j.neo.2022.100806_bib0019","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4161\/cbt.21783","article-title":"Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea","volume":"13","author":"Bowen","year":"2012","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"10.1016\/j.neo.2022.100806_bib0020","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/jn\/126.10.2519","article-title":"Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats","volume":"126","author":"Howarth","year":"1996","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.neo.2022.100806_bib0021","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/1535-7163.MCT-15-0990","article-title":"Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms","volume":"15","author":"Wardill","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"16","key":"10.1016\/j.neo.2022.100806_bib0022","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/bioinformatics\/bts342","article-title":"Associating microbiome composition with environmental covariates using generalized UniFrac distances","volume":"28","author":"Chen","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2022.100806_bib0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fmicb.2018.00365","article-title":"BURRITO: An Interactive Multi-Omic Tool for Visualizing Taxa-Function Relationships in Microbiome Data","volume":"9","author":"McNally","year":"2018","journal-title":"Front Microbiol"},{"issue":"21","key":"10.1016\/j.neo.2022.100806_bib0024","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","article-title":"STAMP: statistical analysis of taxonomic and functional profiles","volume":"30","author":"Parks","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2022.100806_bib0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/JIR.S178288","article-title":"Sex differences of inflammation in target organs, induced by intraperitoneal injection of lipopolysaccharide, depend on its dose","volume":"11","author":"Kosyreva","year":"2018","journal-title":"J Inflamm Res"},{"issue":"9","key":"10.1016\/j.neo.2022.100806_bib0026","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol"},{"issue":"9","key":"10.1016\/j.neo.2022.100806_bib0027","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.neo.2022.100806_bib0028","first-page":"1719","article-title":"Drug-drug interactions in patients using tyrosine kinase inhibitors: a multicenter retrospective study","volume":"24","author":"Ergun","year":"2019","journal-title":"J BUON"},{"issue":"6","key":"10.1016\/j.neo.2022.100806_bib0029","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.neo.2022.100806_bib0030","author":"Neomycin, in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012"},{"issue":"5","key":"10.1016\/j.neo.2022.100806_bib0031","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/01.smj.0000216477.06918.a3","article-title":"Significant absorption of oral vancomycin in a patient with clostridium difficile colitis and normal renal function","volume":"99","author":"Aradhyula","year":"2006","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.neo.2022.100806_bib0032","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1399-302X.2003.00075.x","article-title":"Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria","volume":"18","author":"Von Bultzingslowen","year":"2003","journal-title":"Oral Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.neo.2022.100806_bib0033","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2613.2009.00671.x","article-title":"Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile","volume":"90","author":"Stringer","year":"2009","journal-title":"Int J Exp Pathol"},{"issue":"12","key":"10.1016\/j.neo.2022.100806_bib0034","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4161\/cbt.7.12.6940","article-title":"Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats","volume":"7","author":"Stringer","year":"2008","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"10.1016\/j.neo.2022.100806_bib0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.neo.2022.100806_bib0036","first-page":"1136","article-title":"Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients","volume":"7","author":"Kehrer","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.neo.2022.100806_bib0037","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/15287390802328630","article-title":"Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats","volume":"71","author":"Abou-Donia","year":"2008","journal-title":"J Toxicol Environ Health A"},{"issue":"5","key":"10.1016\/j.neo.2022.100806_bib0038","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/17474124.2019.1595586","article-title":"Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis","volume":"13","author":"Al-Qadami","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.neo.2022.100806_bib0039","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nn.4606","article-title":"Gut microbiota is critical for the induction of chemotherapy-induced pain","volume":"20","author":"Shen","year":"2017","journal-title":"Nat Neurosci"},{"issue":"18","key":"10.1016\/j.neo.2022.100806_bib0040","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/15287394.2018.1502560","article-title":"Intestinal Metabolism and Bioaccumulation of Sucralose In Adipose Tissue In The Rat","volume":"81","author":"Bornemann","year":"2018","journal-title":"J Toxicol Environ Health A"},{"issue":"1","key":"10.1016\/j.neo.2022.100806_bib0041","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/10773525.2015.1106075","article-title":"Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male Swiss mice","volume":"22","author":"Soffritti","year":"2016","journal-title":"Int J Occup Environ Health"},{"issue":"23","key":"10.1016\/j.neo.2022.100806_bib0042","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1158\/1078-0432.CCR-15-0724","article-title":"Stool bacteriomic profiling in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor-tyrosine kinase inhibitors","volume":"21","author":"Pal","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.neo.2022.100806_bib0043","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SPC.0000000000000265","article-title":"Determining risk of severe gastrointestinal toxicity based on pretreatment gut microbial community in patients receiving cancer treatment: a new predictive strategy in the quest for personalized cancer medicine","volume":"11","author":"Wardill","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"issue":"7","key":"10.1016\/j.neo.2022.100806_bib0044","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ctrv.2015.05.011","article-title":"ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: chloride secretion as a mechanistic hypothesis","volume":"41","author":"Van Sebille","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.neo.2022.100806_bib0045","first-page":"59","article-title":"Pre-treatment Blautia abundance regulates chemotherapy-induced gastrointestinal toxicity risk: a pilot study","volume":"14","author":"Secombe","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"issue":"8","key":"10.1016\/j.neo.2022.100806_bib0046","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","article-title":"Intestinal blautia is associated with reduced death from graft-versus-host disease","volume":"21","author":"Jenq","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.neo.2022.100806_bib0047","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chom.2017.03.010","article-title":"The gut microbiome: connecting spatial organization to function","volume":"21","author":"Tropini","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.neo.2022.100806_bib0048","doi-asserted-by":"crossref","first-page":"164","DOI":"10.15252\/embr.201439263","article-title":"The composition of the gut microbiota shapes the colon mucus barrier","volume":"16","author":"Jakobsson","year":"2015","journal-title":"EMBO Rep"},{"issue":"2","key":"10.1016\/j.neo.2022.100806_bib0049","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10549-019-05472-w","article-title":"Untapped \"-omics\": the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment","volume":"179","author":"Komorowski","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.neo.2022.100806_bib0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/annonc\/mdz249.070","article-title":"Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota \u2018guilds\u2019 in renal cell carcinoma (RCC) patients","volume":"30","author":"Iebba","year":"2019","journal-title":"Ann Oncol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:10:52Z","timestamp":1761484252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":50,"alternative-id":["S1476558622000331"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100806","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100806"}}